800
M.B. Baker et al.
33.61, 70.17, 115.12 (d, J ¼ 22.3 Hz), 120.52 (d,
J ¼ 7.7 Hz), 135.73, 157.71 (d, J ¼ 238 Hz), 167.45,
198.25. HR-MS (DART): calculated for C33H28F3N4O6
[M þ H]þ 633.1961, found 633.1979.
2,20-((1s,3r,5s,7r)-4,6,10-Trioxo-7-(2-oxo-2-(phenylamino)
ethyl)-1-azaadamantane-3,5-diyl)bis(N-(4-dodecylphenyl)
acetamide) (1m)
To a solution of 4m (51 mg, 59 mmol) in i-PrOH was
added, HMTA (17 mg, 120 mmol) and the reaction mixture
was allowed to reflux over 2 nights. After cooling, the
insoluble material was isolated by filtration and washed
with 0.1 N HCl, i-PrOH and EtOAc before being dried in
vacuo to yield 1m (30 mg, 56%) as a white, flaky solid. 1H
NMR (d6-DMSO): d 0.85 (t, J ¼ 6.7 Hz, 6H), 1.23 (br s,
36H), 1.52 (m, 4H), 2.77 (m, 6H), 3.91 (m, 6H), 7.00
(t, J ¼ 7.3 Hz, 1H), 7.05 (d, J ¼ 8.2 Hz, 4H), 7.25
(t, J ¼ 7.8 Hz, 2H), 7.41 (d, J ¼ 8.1 Hz, 4H), 7.53
(d, J ¼ 8.0 Hz, 2H), 9.82 (s, 2H), 9.93 (s, 1H). 13C NMR
(d6-DMSO): d 13.76, 21.92, 28.41, 28.52, 28.69, 28.82,
28.85, 30.83, 31.12, 33.57, 34.38, 70.11, 70.23, 118.85,
118.92, 122.72, 128.10, 128.40, 136.67, 136.84, 139.18,
167.18, 167.41, 198.12, 198.16. HR-MS (ESI): calculated
for C57H79N4O6 [M þ H]þ 915.5994, found 915.5981.
N-(4-Methylesterphenyl)-2-(4,6,10-trioxo-5,7-di-4-methyl-
esterphenylcarbamoylmethyl-1-aza-tricyclo[3.3.1.13,7]
dec-3-yl)-acetamide (1h)
To a solution of 4h (42 mg, 60 mmol) in i-PrOH was added,
HMTA (25 mg, 180 mmol) and the reaction mixture was
heated to reflux over 3 nights. Solids from the reaction
mixture were removed by filtration, then washed and dried
to yield compound 1h (10 mg, 21%) as a slightly tan
powder. 1H NMR (d6-DMSO): d 2.82 (s, 6H), 3.81 (s, 9H),
3.93 (s, 6H), 7.67 (d, J ¼ 7.7 Hz, 6H), 7.88 (d, J ¼ 7.4 Hz,
6H), 10.40 (s, 3H). 13C NMR (d6-DMSO): d 33.81, 51.73,
70.16, 70.37, 118.17, 123.55, 130.15, 143.57, 165.74,
168.05, 198.27. HR-MS (ESI): calculated for
C39H37N4O12 [M þ H]þ 753.2402, found 753.2416.
2,20,200-((3s,5s,7s)-4,6,10-Trioxo-1-azaadamantane-3,5,7-
triyl)tris(N-(naphthalen-2-yl)acetamide) (1i)
2,20-((1r,3r,5s,7s)-7-(2-(Naphthalen-2-ylamino)-2-
oxoethyl)-4,6,10-trioxo-1-azaadamantane-3,5-diyl)bis(N-
phenylacetamide) (1n)
To a solution of 4i (49 mg, 0.072 mmol) in i-PrOH was
added, HMTA (30 mg, 0.22 mmol) and the reaction
mixture was heated to reflux for 120 h. After cooling, the
insoluble material was isolated, triturated with EtOAc,
isolated by filtration and washed to yield 1i (35 mg, 66%)
as a slightly tan solid. 1H NMR (d6-DMSO): d 2.88 (s, 6H),
4.00 (s, 6H), 7.37 (m, 3H), 7.44 (t, J ¼ 7.5 Hz, 3H), 7.52
(d, J ¼ 8.6 Hz, 3H), 7.80 (m, 9H), 8.29 (s, 3H), 10.24
(s, 3H). 13C NMR (d6-DMSO): d 33.84, 70.28, 70.46,
114.74, 119.80, 124.35, 126.31, 127.19, 127.38, 128.22,
129.54, 133.44, 136.51, 167.61, 198.31. HR-MS (ESI):
calculated for C45H36N4O6Na [M þ Na]þ 751.2517,
found 751.2517.
A solution of 4n (90 mg, 0.16 mmol), HMTA (66 mg,
0.48 mmol) and i-PrOH (5 ml) was heated to reflux for
2 days. After cooling to room temperature, the mixture was
filtered to afford an off-white solid. The solid was washed
with 5% HCl and water to afford 1n (41 mg, 43%) as an
off-white solid. 1H NMR (d6-DMSO): d 2.79 (s, 4H), 2.85
(s, 2H), 3.95 (s, 6H), 6.99 (t, J ¼ 7.5 Hz, 2H), 7.26 (t,
J ¼ 7.8 Hz, 4H), 7.45 (m, 8H), 7.81 (m, 3H), 8.27 (s, 1H),
10.01 (s, 2H), 10.23 (s, 1H). 13C NMR (d6-DMSO): d
33.21, 69.71, 69.88, 114.19, 118.35, 119.28, 122.33,
123.85, 125.81, 126.69, 126.88, 127.72, 128.08, 129.03,
132.95, 136.36, 138.80, 167.03, 167.28, 197.79. HR-MS
(ESI): calculated for C37H32N4O6 Na [M þ Na]þ
651.2214, found 651.2208.
2,20,200-((3s,5s,7s)-4,6,10-Trioxo-1-azaadamantane-3,5,7-
triyl)tris(N-(7-dodecyl-naphthalen-2-yl)acetamide) (1j)
To a solution of 4j (25 mg, 0.021 mmol) in i-PrOH was
added, HMTA (8.8 mg, 0.063 mmol) and the reaction
mixture was allowed to reflux for 120 h. After cooling, the
insoluble material was isolated, triturated with EtOAc,
again isolated by filtration and washed to yield 1j (17 mg,
2,20-(4,6-Dihydroxy-2-oxo-2,3-dihydrobenzofuran-5,7-
diyl)bis(N-phenylacetamide) (5)
To a solution of BTF (100 mg, 0.40 mmol) in DMF (2 ml)
was added dropwise, aniline solution (3.2 ml of a 0.5 M
solution, 1.6 mmol). The resulting solution was stirred
over 2 nights in a 708C oil bath, after which the reaction
was diluted with EtOAc (200 ml), washed with 0.3 N HCl,
DI H2O, then brine and dried over Na2SO4. The solvent
was removed in vacuo and the residue was purified by
column chromatography (1/10 acetone/DCM) to yield 5
(79 mg, 45%) as an off-white solid. 1H NMR (d6-DMSO):
d 3.67 (s, 2H), 3.68 (s, 2H), 3.74 (s, 2H), 7.03 (q,
J ¼ 7.6 Hz, 2 H), 7.34–7.23 (m, 4H), 7.59 (d, J ¼ 7.9 Hz,
4 H), 9.55 (s, 1 H), 9.70 (s, 1 H), 10.05 (s, 1 H), 10.24 (s,
1
65%) as a white powder. H NMR (d5-pyridine): d 0.87
(t, J ¼ 6.9 Hz, 9H), 1.29 (m, 60H), 1.67 (m, 6H), 2.73
(t, J ¼ 7.6 Hz, 6H), 4.37 (s, 6H), 7.38 (d, J ¼ 8.2 Hz, 3H),
7.68 (s, 3H), 7.8 (d, J ¼ 8.5 Hz, 3H), 7.87 (m, 6H), 8.61 (s,
3H), 11.73 (s, 3H). 13C NMR (d5-pyridine): d 14.98, 23.63,
26.75, 28.34, 30.30, 30.33, 30.53, 30.60, 30.65, 32.40,
32.81, 36.90, 72.11, 75.87, 117.39, 121.57, 127.24,
128.55, 129.02, 131.75, 133.74, 140.11, 169.59, 200.21.
HR-MS (ESI): calculated for C81H108N4O6Na [M þ Na]þ
1255.8167, found 1255.8136.